The Oladipupo Foundation has called on the Federal Government to subsidise sickle cell transplant procedures in Nigeria, arguing that the high cost of treatment has placed a potentially curative medical intervention beyond the reach of many patients living with the condition.
The foundation made the appeal as part of efforts to draw attention to the challenges faced by individuals battling sickle cell disease, one of the most prevalent inherited blood disorders in Nigeria and across sub-Saharan Africa.
Speaking on the issue, representatives of the foundation said bone marrow and stem cell transplants remain among the most effective treatment options capable of offering a cure for sickle cell disease. However, they noted that the procedure is often prohibitively expensive, making it inaccessible to a large number of patients and their families.
According to the organisation, many Nigerians living with sickle cell disorder continue to endure recurrent health complications, frequent hospital admissions, severe pain crises, and reduced quality of life because they cannot afford advanced treatment options.
The foundation urged the Federal Government to introduce subsidies and financial support mechanisms that would significantly reduce the cost of transplant procedures. It argued that such intervention would help save lives and improve health outcomes for thousands of affected individuals.
The group also called for the inclusion of sickle cell transplant procedures in government-backed healthcare financing programmes and health insurance schemes, noting that broader coverage would ease the financial burden on patients and encourage more people to seek treatment.
Nigeria is widely regarded as one of the countries with the highest burden of sickle cell disease globally, with thousands of children born annually with the condition. Health experts have consistently emphasized the need for greater investment in awareness, early diagnosis, preventive screening, and access to specialized care.
The Oladipupo Foundation noted that while advances in medical science have improved treatment outcomes for sickle cell patients, access remains limited due to the high cost of care, inadequate infrastructure, and a shortage of specialised treatment centres.
The organisation further urged policymakers to invest in modern transplant facilities and support research aimed at improving treatment options for patients across the country. It stressed that a comprehensive approach involving government agencies, healthcare providers, private sector stakeholders, and development partners would be necessary to address the burden of the disease effectively.
Medical experts have long advocated increased public awareness of genotype testing and genetic counselling as part of efforts to reduce the incidence of sickle cell disease. They also maintain that improved access to specialised healthcare services remains critical to managing the condition and reducing mortality rates.
The foundation’s appeal comes amid growing advocacy by health organisations and patient support groups for stronger government intervention in the fight against sickle cell disease, which continues to affect millions of Nigerians directly and indirectly.
Stakeholders say subsidising transplant procedures could represent a major step toward improving healthcare equity and ensuring that patients are not denied potentially lifesaving treatment because of financial constraints.
As discussions continue, advocates hope the government will consider measures that make advanced sickle cell treatment more affordable and accessible, while strengthening broader efforts to combat one of the country’s most significant public health challenges.
